Extendicare Inc. (TSE:EXE – Free Report) – Leede Financial upped their FY2025 earnings estimates for shares of Extendicare in a research report issued to clients and investors on Wednesday, November 13th. Leede Financial analyst D. Loe now expects that the company will earn $1.29 per share for the year, up from their prior forecast of $0.90. The consensus estimate for Extendicare’s current full-year earnings is $0.61 per share. Leede Financial also issued estimates for Extendicare’s FY2026 earnings at $1.39 EPS.
Several other analysts have also weighed in on EXE. TD Securities boosted their price objective on Extendicare from C$9.50 to C$10.50 and gave the company a “hold” rating in a report on Thursday, November 14th. Royal Bank of Canada upped their price target on Extendicare from C$8.50 to C$9.50 in a research report on Monday, August 19th.
Extendicare Price Performance
EXE opened at C$10.09 on Monday. The company has a market capitalization of C$842.21 million, a P/E ratio of 14.84 and a beta of 1.26. The company has a 50-day moving average of C$9.30 and a 200-day moving average of C$8.18. The company has a debt-to-equity ratio of 305.80, a quick ratio of 0.98 and a current ratio of 0.60. Extendicare has a 1-year low of C$6.45 and a 1-year high of C$10.43.
Extendicare Announces Dividend
The business also recently declared a monthly dividend, which was paid on Friday, November 15th. Stockholders of record on Thursday, October 31st were given a dividend of $0.04 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 4.76%. The ex-dividend date was Thursday, October 31st. Extendicare’s payout ratio is 70.59%.
About Extendicare
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
See Also
- Five stocks we like better than Extendicare
- What Do S&P 500 Stocks Tell Investors About the Market?
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- What is a Bond Market Holiday? How to Invest and Trade
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 3 Hot Stock Trends to Ride Into 2025
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
